– AGB101 is the first investigational therapeutic that targets the reduction of hippocampal overactivity. – The study evaluates both Primary and Secondary Endpoints to measure cognitive and functional efficacy. – Secondary imaging endpoints will...
Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today it had entered into a collaboration agreement with Nassau based Foot and Ankle International (Bahamas) to conduct two Phase 2 cDFU clinical trial for its topically...
-PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced PharmaCyte’s partner, Austrianova, has...
Can krill oil improve the quality of life of people living with systemic lupus erythematous? A clinical trial, involving 20 centers in the United States, is currently enrolling patients to answer this question. Hospital for Special Surgery (HSS), in New York City, is...
Robert Dworkin, Ph.D. Joins Lotus Clinical Research as Director, Chronic Pain Research to lead Lotus’ chronic pain research programs Lotus Clinical Research, a specialty analgesic full-service CRO, has announced the addition of Robert (Bob) Dworkin, Ph.D. as...
Email
Text